Gainers
- Biopharmx Corp BPMX shares rose 72.8% to $1.53 in pre-market trading after the company announced that its Phase 2b trial of BPX-04 for Populopustular Rosacea met both primary and secondary endpoints and was well tolerated.
- Allergan plc AGN shares rose 29.1% to $167.31 in pre-market trading after AbbVie Inc ABBV announced plans To acquire Allergan for $188.24 per share in cash and stock.
- Riot Blockchain, Inc. RIOT shares rose 15.8% to $3.52 in pre-market trading after climbing 10.55% on Monday.
- India Globalization Capital, Inc. IGC rose 10.8% to $2.27 in pre-market trading after surging 25.77% on Monday.
- Jaguar Health, Inc. JAGX rose 9.7% to $5.00 in pre-market trading. Jaguar Health regained compliance with all applicable Nasdaq Stock Market listing standards.
- scPharmaceuticals Inc. SCPH rose 4.8% to $3.07 in pre-market trading.
- Endo International plc ENDP rose 4.7% to $3.76 in pre-market trading after dropping 6.51% on Monday.
- Krystal Biotech Inc KRYS rose 4.4% to $43.00 in pre-market trading. Krystal Biotech priced 2.5 million share public offering of common stock at $40 per share.
- Lennar Corporation LEN rose 4.1% to $53.51 in pre-market trading after the company announced better-than-expected results for its second quarter.
- ArQule, Inc. ARQL rose 4% to $10.41 in pre-market trading. ArQule priced 9.25 million share offering at $9.75 per share.
- FactSet Research Systems Inc. FDS rose 4% to $305.06 in pre-market trading after reporting upbeat Q3 results.
- Can-Fite BioPharma Ltd. CANF rose 3.6% to $2.89 in pre-market trading after declining 6.08% on Monday.
- Bausch Health Companies Inc BHC rose 3.5% to $24.60 in pre-market trading after the company announced the US launch of DUOBRII lotion 0.01%/0.045% for plaque psoriasis in adults.
- Genfit SA GNFT rose 3.4% to $20.90 in pre-market trading after announcing a strategic partnership with Terns Pharmaceuticals to develop and commercialize elafibranor in Greater China. The company will receive an upfront payment of $35 million.
- Sibanye Gold Limited SBGL shares rose 3.4% to $4.82 in pre-market trading.
- Grubhub Inc. GRUB rose 3.2% to $74.50 in pre-market trading. Citigroup upgraded GrubHub from Neutral to Buy.
- Nabriva Therapeutics PLC – ADR NBRV rose 2% to $2.14 in pre-market trading after reporting the EMA validated the marketing authorization application for lufamulin.
Â
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Conatus Pharmaceuticals Inc CNAT fell 57.7% to $0.39 in pre-market trading after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.
- Aldeyra Therapeutics Inc ALDX fell 23.4% to $5.43 in pre-market trading after the company announced its SOLACE trial in noninfectious anterior uveitis did not achieve statistical significance in its primary or secondary endpoints.
- Akerna Corp. KERN shares fell 11.2% to $24.01 in pre-market trading after dropping 14.09% on Monday.
- Immunic, Inc. IMUX fell 10.7% to $15.86 in pre-market trading after rising 90.86% on Monday.
- Gamida Cell Ltd GMDA fell 9.9% to $6.50 in pre-market trading after the company filed for a common stock offering of 4.04 million shares.
- AbbVie Inc. ABBV fell 8.9% to $71.50 in pre-market trading after the company announced it will acquire Allergan for $188.24/share.
- Brighthouse Financial, Inc. BHF shares fell 7.2% to $35.40 in pre-market trading. Credit Suisse downgraded Brighthouse Financial from Neutral to Underperform and lowered the price target from $35 to $22, while Goldman Sachs downgraded the stock from Neutral to Sell and lowered the price target from $39 to $32.
- The Medicines Company MDCO fell 4.6% to $33.73 in pre-market trading after reporting a $150 million common stock offering.
- Pivotal Software, Inc. PVTL fell 4.4% to $10.85 in pre-market trading.
- AMAG Pharmaceuticals, Inc. AMAG fell 3.6% to $8.25 in pre-market trading after dropping 4.57% on Monday.
- Beyond Meat, Inc. BYND fell 3.4% to $136.19 in pre-market trading after dropping 8.53% on Monday.
- Shopify Inc. SHOP fell 2.8% to $303.30 in pre-market trading. Wedbush downgraded Shopify from Outperform to Neutral.
- Minerva Neurosciences, Inc. NERV fell 2.7% to $5.77 in pre-market trading after surging 40.19% on Monday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: #PreMarket GainersConsumer DiscretionaryHomebuildingLosersTop GainersNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral